C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/85 (2006.01) C12N 5/0783 (2010.01) A61K 35/12 (2006.01) A61K 38/20 (2006.01) A61P 35/00 (2006.01) C12N 5/10 (2006.01) C12N 15/00 (2006.01) C12N 15/861 (2006.01) C12Q 1/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/50 (2006.01) G01N 33/53 (2006.01) G01N 33/68 (2006.01) C12N 15/24 (2006.01)
Patent
CA 2739902
This invention relates to the field of therapeutics. Most specifically invention provides methods of generating in vitro engineered immune cells conditionally expressing interleukin-12 (IL- 12) and one or more immunomodulators under the control of a gene expression modulation system in the presence of activating ligand and uses for therapeutic purposes in animals.
Linvention concerne le domaine de la thérapeutique. Linvention concerne de manière plus spécifique des cellules immunes modifiées in vitro exprimant de manière conditionnelle une interleukine-12 (IL- 12) et un ou plusieurs immunomodulateurs sous le contrôle dun système de modulation dexpression génique en présence dun ligand dactivation. Linvention concerne également des cellules modifées à des fins thérapeutiques pour les animaux.
Beech Robert Patterson
Reed Thomas D.
Intrexon Corporation
Mbm Intellectual Property Law Llp
LandOfFree
Engineered cells expressing multiple immunomodulators and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Engineered cells expressing multiple immunomodulators and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Engineered cells expressing multiple immunomodulators and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2007373